The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Priorix-Tetra powder and solvent for solution for injection in pre-filled syringe Measles, mumps, rubella and varicella vaccine (live)



GlaxoSmithKline (Ireland) LimitedPA1077/117/001

Main Information

Trade NamePriorix-Tetra powder and solvent for solution for injection in pre-filled syringe Measles, mumps, rubella and varicella vaccine (live)
Active SubstancesLive attenuated measles virus (schwarz strain)
Live attenuated mumps virus (rit 4385 strain)
Live attenuated rubella virus (wistar ra 27/3 strain)
Live attenuated varicella virus (oka strain)
Dosage FormPowder and solvent for solution for injection in pre-filled syringe
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/117/001

Group Information

ATC CodeJ07BD Measles vaccines
J07BD54 measles, combinations with mumps, rubella and varicella, live attenuated

Status

License statusAuthorised
Licence Issued10/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back